Listing of Every Candidate for Birmingham City Council Seats birminghamtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from birminghamtimes.com Daily Mail and Mail on Sunday newspapers.
American Red Cross names Michigan native to lead state s blood services unit
American Red Cross names Michigan native to lead state s blood services unit
Brings a decade of experience in leading blood collection efforts for nonprofit
Most recently managed collections in eastern New York
American Red Cross
American Red Cross Blood Services, Michigan Region has named a new top executive.
Jacqueline Tullio, an Algonac native, is returning to Michigan from New York to serve as regional donor services executive.
Tullio, 39, brings 10 years of experience in overseeing blood collection efforts for the Red Cross.
Most recently, she managed the collections department for the Albany district in eastern New York for two and a half years.
Sickle Cell Disease Treatment Market to Exhibit a CAGR of 18.5% and Reach USD 7.71 Billion by 2027; FDA Approval for Emmaus’s Endari to Aid Development, states Fortune Business Insights™ Key Prominent Players Covered in the Sickle Cell Disease Treatment Market Research Report Are Novartis AG (Basel, Switzerland), Global Blood Therapeutics Inc. (California, U.S.), Emmaus Medical Inc. (California, U.S.), Addmedica (Paris, France), Medunik USA Inc. (Pennsylvania, U.S.), Bristol-Myers Squibb Company (New York City, U.S.) and other key market players.
January 20, 2021 08:56 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, Jan. 20, 2021 (GLOBE NEWSWIRE) The
global sickle cell disease treatment market size is expected to reach USD 7.71 billion in 2027, exhibiting a CAGR of 18.5% during the forecast period. The unmet needs of patients and lack of novel therapies has resulted in research grants from governm
January 12, 2021
As the number of COVID-19 hospitalizations has increased, the American Red Cross has begun to distribute record numbers of convalescent plasma products, leading to a shortage. (Illustration/iStock)
Sarah Castillo witnessed firsthand how convalescent plasma plasma from individuals who have recovered from COVID-19 can help patients hit hard by the virus.
The USC graduate student was living with her parents, brother and uncle in small-town Illinois in May when her uncle became concerned that he may have contracted the virus.
“He called me while he was waiting for his test results to say he couldn’t breathe. He only speaks Spanish, so I’m the one he calls. I told him to call 9-1-1,” Castillo recalled. “He couldn’t even stand. I had to help him into the ambulance.”